Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory

Clinical Chemistry

Volumn 56, Issue 8, 2010, Pages 1234-1244

  Vogeser, Michael ^a   Seger, Christoph ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ASCOMYCIN; CYCLOSPORIN; DEOXYCORTICOSTERONE; EVEROLIMUS; HYDROXYPROGESTERONE; TACROLIMUS;

ACCURACY; ALGORITHM; ANALYTIC METHOD; ATMOSPHERIC PRESSURE; CLINICAL LABORATORY; DRUG MONITORING; HUMAN; IONIZATION; ISOMER; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRECIPITATION; QUANTITATIVE ANALYSIS; REVIEW; STANDARD; TANDEM MASS SPECTROMETRY;

CALIBRATION; CHROMATOGRAPHY, LIQUID; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; REFERENCE STANDARDS; TANDEM MASS SPECTROMETRY;

EID: 77955246441     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.138602     Document Type: Review

References (64)

1. Saint-Marcoux F, Sauvage FL, Marquet P. Current role of LC-MS in therapeutic drug monitoring. Anal Bioanal Chem 2007;388:1327-49. (Pubitemid 47150864)
2. Kushnir MM, Rockwood AL, Bergquist J. Liquid chromatography-tandem mass spectrometry applications in endocrinology. Mass Spectrom Rev 2010;29:480-502.
3. Vogeser M, Seger C. A decade of HPLC-MS/MS in the routine clinical laboratory: goals for further developments. Clin Biochem 2008;41:649-62.
4. Allen KR. Interference by venlafaxine ingestion in the detection of tramadol by liquid chromatography linked to tandem mass spectrometry for the screening of illicit drugs in human urine. Clin Toxicol 2006;44:147-53.
5. Vogeser M, Zachoval R, Spöhrer U, Jacob K. Potential lack of specificity using electrospray tandem-mass spectrometry for the analysis of mycophenolic acid in serum. Ther Drug Monit 2001;23:722-4. (Pubitemid 33086505)
6. Vogeser M, Spöhrer U. Pitfall in the high-throughput quantification of whole blood cyclosporin A using liquid chromatography-tandem mass spectrometry. Clin Chem Lab Med 2005;43: 400-2. (Pubitemid 41460646)
7. Singh RJ. Are clinical laboratories prepared for accurate testing of 25-hydroxy vitamin D? Clin Chem 2008;54:221-3.
8. Carter GD, Jones JC. Use of a common standard improves the performance of liquid chromatography-tandem mass spectrometry methods for serum 25-hydroxyvitamin-D. Ann Clin Biochem 2009;46:79-81.
9. Carter GD. 25-Hydroxyvitamin D assays: the quest for accuracy. Clin Chem 2009;55:1300-2.
10. Hoofnagle AN. Quantitative clinical proteomics by liquid chromatography-tandem mass spectrometry: assessing the platform. Clin Chem 2010;56:161-4.
11. Hortin GL. Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice? [Editorial]. Clin Chem 2005;51:3-5.
12. Carr SA, Anderson L. Protein quantitation through targeted mass spectrometry: the way out of biomarker purgatory [Editorial]? Clin Chem 2008;54:1749-52.
13. Keshishian H, Addona T, Burgess M, Mani DR, Shi X, Kuhn E, et al. Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics 2009;8:2339-49.
14. Kuhn E, Addona T, Keshishian H, Burgess M, Mani DR, Lee RT, et al. Developing multiplexed assays for troponin I and interleukin-33 in plasma by peptide immunoaffinity enrichment and targeted mass spectrometry. Clin Chem 2009;55: 1108-17.
15. Keshishian H, Addona T, Burgess M, Kuhn E, Carr SA. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol Cell Proteomics 2007;6:2212-29.
16. Kebarle P, Verkerk UH. Electrospray: from ions in solution to ions in the gas phase, what we know now. Mass Spectrom Rev 2009;28:898-917.
17. Covey TR, Thomson BA, Schneider BB. Atmospheric pressure ion sources. Mass Spectrom Rev 2009;28:870-97.
18. Lagerwerf FM, van Dongen WD, Steenvoorden RJJM, Honing M, Jonkman JHG. Exploring the boundaries of bioanalytical quantitative LC-MS-MS. Trends Analyt Chem 2000;19:418-27. (Pubitemid 30365129)
19. Annesley TM. Ion suppression in mass spectrometry. Clin. Chem 2003;49:1041-4.
20. Taylor PJ. Matrix effects: the Achilles heel of quantitative high-performance liquid chromatographyelectrospray-tandem mass spectrometry. Clin Biochem 2005;38:328-34.
21. Annesley TM. Methanol-associated matrix effects in electrospray ionization tandem mass spectrometry. Clin Chem 2007;53:1827-34.
22. Napoli KL. More on methanol-associated matrix effects in electrospray ionization mass spectrometry. Clin Chem 2009;55:1250-2.
23. Keller BO, Sui J, Young AB, Whittal RM. Interferences and contaminants encountered in modern mass spectrometry. Anal Chim Acta 2008;627: 71-81.
24. Guo X, Bruins AP, Covey TR. Characterization of typical chemical background interferences in atmospheric pressure ionization liquid chromatographymass spectrometry. Rapid Commun Mass Spectrom 2006;20:3145-50. (Pubitemid 44569795)
25. Bonfiglio R, King RC, Olah TV, Merkle K. The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun Mass Spectrom 1999;13:1175-85. (Pubitemid 29285118)
26. Matuszewski BK, Constanzer ML, Chavez-Eng EM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 2003;75:3019-30.
27. Gustavsson E, Andersson M, Stephanson N, Beck O. Validation of direct injection electrospray LCMS/ MS for confirmation of opiates in urine drug testing. J Mass Spectrom 2007;42:881-9. (Pubitemid 47057070)
28. Thienpont LM, Van Uytfanghe K, Blincko S, Ramsay CS, Xie H, Doss RC, et al. State-of-the-art of serum testosterone measurement by isotope dilution-liquid chromatography-tandem mass spectrometry. Clin Chem 2008;54:1290-7.
29. Wang S, Cyronak M, Yang E. Does a stable isotopically labeled internal standard always correct analyte response? A matrix effect study on a LC/MS/MS method for the determination of carvedilol enantiomers in human plasma. J Pharm Biomed Anal 2007;43:701-7. (Pubitemid 46001699)
30. Lindegardh N, Annerberg A, White NJ, Day NP. Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma stable isotope labeled internal standard does not always compensate for matrix effects. J Chromatogr B Analyt Technol Biomed Life Sci 2008;862:227-36.
31. Stokvis E, Rosing H, Beijnen JH. Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not? Rapid Commun Mass Spectrom 2005;19:401-7.
32. Sauvage FL, Stanke-Labesque F, Gagnieu MC, Jourdil JF, Babany G, Marquet P. Feasibility of ribavirin therapeutic drug monitoring in hepatitis C. Ther Drug Monit 2009;31:374-81.
33. Vogeser M. Instrument-specific matrix effects of calibration materials in the LC-MS/MS analysis of tacrolimus. Clin Chem 2008;54:1406-8.
34. Xuan Y, Creese AJ, Horner JA, Cooper HJ. High-field asymmetric waveform ion mobility spectrometry (FAIMS) coupled with high-resolution electron transfer dissociation mass spectrometry for the analysis of isobaric phosphopeptides. Rapid Commun Mass Spectrom 2009;23:1963-9.
35. Yan Z, Caldwell GC, Jones WJ, Masucci JA. Cone voltage induced in-source dissociation of glucuronides in electrospray and implications in biological analyses. Rapid Commun Mass Spectrom 2006;17:1433-42. (Pubitemid 36791149)
36. CLSI. Mass spectrometry in the clinical laboratory: general principles and guidance; approved guideline. CLSI document C50-A. Wayne (PA): CLSI; 2007.
37. Sherman J, McKay MJ, Ashman K, Molloy MP. How specific is my SRM?: The issue of precursor and product ion redundancy. Proteomics 2009;9: 1120-3.
38. Jaffe JD, Keshishian H, Chang B, Addona TA, Gillette MA, Carr SA. Accurate inclusion mass screening: a bridge from unbiased discovery to targeted assay development for biomarker verification. Mol Cell Proteomics 2008;1952-62.
39. Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 2009;37: D603-10.
40. Anderson NL. The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. Clin Chem 2010;56:177-85.
41. Kushnir MM, Rockwood AL, Nelson GJ, Yue B, Urry FM. Assessing analytical specificity in quantitative analysis using tandem mass spectrometry. Clin Biochem 2005;38:319-27. (Pubitemid 40342862)
42. Careri M, Mangia A. Validation and qualification: the fitness for purpose of mass spectrometry-based analytical methods and analytical systems. Anal Bioanal Chem 2006;386:38-45. (Pubitemid 44268047)
43. Rauh M, Gröschl M, Rascher W, Dörr HG. Automated, fast and sensitive quantification of 17 alpha-hydroxy-progesterone, androstenedione and testosterone by tandem mass spectrometry with on-line extraction. Steroids 2006;71:450-8. (Pubitemid 44294349)
44. Carvalho VM, Nakamura OH, Vieira JG. Simultaneous quantitation of seven endogenous C-21 adrenal steroids by liquid chromatography tandem mass spectrometry in human serum. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 872:154-61.
45. Oberacher H, Pavlic M, Libiseller K, Schubert B, Sulyok M, Schuhmacher R, et al. On the interinstrument and inter-laboratory transferability of a tandem mass spectral reference library, 1: results of an Austrian multicenter study. J Mass Spectrom 2009;44:485-93.
46. Hopley C, Bristow T, Lubben A, Simpson A, Bull E, Klagkou K, et al. Towards a universal product ion mass spectral library: reproducibility of product ion spectra across eleven different mass spectrometers. Rapid Commun Mass Spectrom 2008; 22:1779-86. (Pubitemid 351947742)
47. Jansen R, Lachatre G, Marquet P. LC-MS/MS systematic toxicological analysis: comparison of MS/MS spectra obtained with different instruments and settings. Clin Biochem 2005;38: 362-72. (Pubitemid 40342866)
48. Kaufmann A, Butcher P, Maden K, Widmer M, Giles K, Uria D. Are liquid chromatography/electrospray tandem quadrupole fragmentation ratios unequivocal confirmation criteria? Rapid Commun Mass Spectrom 2009;23:985-98.
49. Marshall AG, Hendrickson CL, Shi SD. Scaling MS plateaus with high-resolution FT-ICRMS. Anal Chem 2002;74:253A-259A.
50. De Hoffmann E, Stroobant V. Mass spectrometry, principles and applications. 3rd ed. Chichester (West Sussex, England); 2007.
51. Kind T, Fiehn O. Metabolomic database annotations via query of elemental compositions: Mass accuracy is insufficient even at less than 1 ppm. BMC Bioinformatics 2006;7:234. (Pubitemid 43750377)
52. Calbiani F, Careri M, Elviri L, Mangia A, Zagnoni I. Matrix effects on accurate mass measurements of low-molecular weight compounds using liquid chromatography-electrospray-quadrupole time-of-flight mass spectrometry. J Mass Spectrom 2006;41:289-94.
53. Mylonas R, Mauron Y, Masselot A, Binz PA, Budin N, Fathi M, et al. X-Rank: a robust algorithm for small molecule identification using tandem mass spectrometry. Anal Chem 2009;81: 7604-10.
54. Zhang H, Henion J. Comparison between liquid chromatography-time-of- flight mass spectrometry and selected reaction monitoring liquid chromatography-mass spectrometry for quantitative determination of idoxifene in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2001;757:151-9. (Pubitemid 32424468)
55. Schrader W, Klein HW. Liquid chromatography/ Fourier transform ion cyclotron resonance mass spectrometry (LC-FTICR MS): an early overview. Anal Bioanal Chem 2004;379:1013-24. (Pubitemid 40877531)
56. Sutton J, Richmond T, Shi X, Athanas M, Ptak C, Gerszten R, Bonilla L. Performance characteristics of an FT MS-based workflow for label-free differential MS analysis of human plasma: standards, reproducibility, targeted feature investigation, and application to a model of controlled myocardial infarction. Proteomics Clin Appl 2008;2:862-81. (Pubitemid 351943767)
57. Hu Q, Noll RJ, Li H, Makarov A, Hardman M, Cooks RG. The Orbitrap: a new mass spectrometer. J Mass Spectrom 2005;40:430-43.
58. Erve JC, Demaio W, Talaat RE. Rapid metabolite identification with sub parts-per-million mass accuracy from biological matrices by direct infusion nanoelectrospray ionization after clean-up on a ZipTip and LTQ/Orbitrap mass spectrometry. Rapid Commun Mass Spectrom 2008;22:3015-26.
59. Havlíková H, Hill M, Hampl R, Stárka L. Sex- and age-related changes in epitestosterone in relation to pregnenolone sulfate and testosterone in normal subjects. J Clin Endocrinol Metab 2002;87: 2225-31. (Pubitemid 34521513)
60. Vogeser M, Schelling G. Pitfalls in measuring the endocannabinoid 2-arachidonoyl glcyerol in biological samples. Clin Chem Lab Med 2007;45: 1023-5. (Pubitemid 47424862)
61. Ionita IA, Fast DM, Akhlaghi F. Development of a sensitive and selective method for the quantitative analysis of cortisol, cortisone, prednisolone and prednisone in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877: 765-72.
62. Lostia AM, Lionetto L, Principessa L, Evangelisti M, Gamba A, Villa MP, Simmaco M. A liquid chromatography/mass spectrometry method for the evaluation of intestinal permeability. Clin Biochem 2008;41:887-92.
63. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations. Anal Chem 1998;70: 882-9.
64. Seger C, Tentschert K, Stöggl W, Griesmacher A, Ramsay SL. A rapid HPLC-MS/MS method for the simultaneous quantification of cyclosporine A, tacrolimus, sirolimus and everolimus in human blood samples. Nat Protoc 2009;4:526-34.